Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study
To reduce vaccine hesitancy, it is important to identify factors that can intervene at the individual or community level. Social capital is a possible factor because it is associated with various vaccine hesitancy, such as for measles and influenza. However, limited studies have explored the associa...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-11-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/21645515.2022.2086773 |
| _version_ | 1797673162892115968 |
|---|---|
| author | Masaki Machida Hiroyuki Kikuchi Takako Kojima Itaru Nakamura Reiko Saito Tomoki Nakaya Tomoya Hanibuchi Tomoko Takamiya Yuko Odagiri Noritoshi Fukushima Shiho Amagasa Hidehiro Watanabe Shigeru Inoue |
| author_facet | Masaki Machida Hiroyuki Kikuchi Takako Kojima Itaru Nakamura Reiko Saito Tomoki Nakaya Tomoya Hanibuchi Tomoko Takamiya Yuko Odagiri Noritoshi Fukushima Shiho Amagasa Hidehiro Watanabe Shigeru Inoue |
| author_sort | Masaki Machida |
| collection | DOAJ |
| description | To reduce vaccine hesitancy, it is important to identify factors that can intervene at the individual or community level. Social capital is a possible factor because it is associated with various vaccine hesitancy, such as for measles and influenza. However, limited studies have explored the association between social capital and vaccination for COVID-19, which is an unprecedented pandemic and infodemic. Therefore, this study aimed to clarify the association between social capital and COVID-19 vaccination during the pandemic. This cross-sectional study used quota sampling for an online-based survey. Participants were asked whether they had previously been vaccinated for COVID-19 and their intention to receive a COVID-19 vaccine booster. Social capital was evaluated using three measures (individual-level civic participation, social cohesion, and reciprocity). Multiple logistic regression analysis was performed to clarify the association between social capital and previous COVID-19 vaccination status as well as intention to receive a COVID-19 booster. Participants were 2,313 individuals, of whom 87.2% had received a COVID-19 vaccine; 72.3% intended to obtain a COVID-19 booster. Individuals with any social capital are more likely to receive a COVID-19 vaccination than those with none (OR: 1.73, 95%CI: 1.18–2.54; OR: 1.58, 95%CI: 1.22–2.05; OR: 3.05, 95%CI: 2.15–4.33). These indicators were also associated with the intention to receive a COVID-19 booster. Thus, our results suggest that among the general public, those with individual-level social capital are more likely to receive a COVID-19 vaccination than those with none. Social capital may be a factor that can reduce vaccine hesitancy during a pandemic. |
| first_indexed | 2024-03-11T21:40:45Z |
| format | Article |
| id | doaj.art-80fdb91c13a343f38351b2cbde8aaeb3 |
| institution | Directory Open Access Journal |
| issn | 2164-5515 2164-554X |
| language | English |
| last_indexed | 2024-03-11T21:40:45Z |
| publishDate | 2022-11-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj.art-80fdb91c13a343f38351b2cbde8aaeb32023-09-26T13:19:07ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2022-11-0118510.1080/21645515.2022.20867732086773Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional studyMasaki Machida0Hiroyuki Kikuchi1Takako Kojima2Itaru Nakamura3Reiko Saito4Tomoki Nakaya5Tomoya Hanibuchi6Tomoko Takamiya7Yuko Odagiri8Noritoshi Fukushima9Shiho Amagasa10Hidehiro Watanabe11Shigeru Inoue12Tokyo Medical UniversityTokyo Medical UniversityTokyo Medical UniversityTokyo Medical University HospitalNiigata UniversityTohoku UniversityTohoku UniversityTokyo Medical UniversityTokyo Medical UniversityTokyo Medical UniversityTokyo Medical UniversityTokyo Medical University HospitalTokyo Medical UniversityTo reduce vaccine hesitancy, it is important to identify factors that can intervene at the individual or community level. Social capital is a possible factor because it is associated with various vaccine hesitancy, such as for measles and influenza. However, limited studies have explored the association between social capital and vaccination for COVID-19, which is an unprecedented pandemic and infodemic. Therefore, this study aimed to clarify the association between social capital and COVID-19 vaccination during the pandemic. This cross-sectional study used quota sampling for an online-based survey. Participants were asked whether they had previously been vaccinated for COVID-19 and their intention to receive a COVID-19 vaccine booster. Social capital was evaluated using three measures (individual-level civic participation, social cohesion, and reciprocity). Multiple logistic regression analysis was performed to clarify the association between social capital and previous COVID-19 vaccination status as well as intention to receive a COVID-19 booster. Participants were 2,313 individuals, of whom 87.2% had received a COVID-19 vaccine; 72.3% intended to obtain a COVID-19 booster. Individuals with any social capital are more likely to receive a COVID-19 vaccination than those with none (OR: 1.73, 95%CI: 1.18–2.54; OR: 1.58, 95%CI: 1.22–2.05; OR: 3.05, 95%CI: 2.15–4.33). These indicators were also associated with the intention to receive a COVID-19 booster. Thus, our results suggest that among the general public, those with individual-level social capital are more likely to receive a COVID-19 vaccination than those with none. Social capital may be a factor that can reduce vaccine hesitancy during a pandemic.http://dx.doi.org/10.1080/21645515.2022.2086773coronavirus diseasemessenger rna vaccinesocial capitalvaccine hesitancyvaccine acceptance |
| spellingShingle | Masaki Machida Hiroyuki Kikuchi Takako Kojima Itaru Nakamura Reiko Saito Tomoki Nakaya Tomoya Hanibuchi Tomoko Takamiya Yuko Odagiri Noritoshi Fukushima Shiho Amagasa Hidehiro Watanabe Shigeru Inoue Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study Human Vaccines & Immunotherapeutics coronavirus disease messenger rna vaccine social capital vaccine hesitancy vaccine acceptance |
| title | Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study |
| title_full | Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study |
| title_fullStr | Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study |
| title_full_unstemmed | Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study |
| title_short | Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study |
| title_sort | individual level social capital and covid 19 vaccine hesitancy in japan a cross sectional study |
| topic | coronavirus disease messenger rna vaccine social capital vaccine hesitancy vaccine acceptance |
| url | http://dx.doi.org/10.1080/21645515.2022.2086773 |
| work_keys_str_mv | AT masakimachida individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy AT hiroyukikikuchi individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy AT takakokojima individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy AT itarunakamura individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy AT reikosaito individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy AT tomokinakaya individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy AT tomoyahanibuchi individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy AT tomokotakamiya individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy AT yukoodagiri individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy AT noritoshifukushima individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy AT shihoamagasa individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy AT hidehirowatanabe individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy AT shigeruinoue individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy |